Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

Clinical trial NCT03760952 · COMPLETED

Trial details

NCT number: NCT03760952
Sponsor: Immatics US, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Refractory Cancer Recurrent Cancer Adult Solid Tumor Neoplasms

Start date: 2019-02-26
Primary completion: 2022-11-15
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.